TY - JOUR
T1 - Cancer treatment–specific medication beliefs among metastatic breast cancer patients
T2 - a qualitative study
AU - Marshall, Victoria K.
AU - Visovsky, Constance
AU - Advani, Pooja
AU - Mussallem, Dawn
AU - Tofthagen, Cindy
N1 - Funding Information:
All data specific to this research article have been stored on a secure database and are available by making a formal request to the primary author, Dr. Victoria K. Marshall, Assistant Professor, University of South Florida, College of Nursing, at vkmarshall@usf.edu. All data, associated codes, and codebooks included in this article are available upon formal request to the primary author, Dr. Victoria K. Marshall, Assistant Professor, University of South Florida, College of Nursing, at vkmarshall@usf.edu.
Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2022/8
Y1 - 2022/8
N2 - Background/significance: Over 168,000 women are living with metastatic breast cancer (MBC) in the USA. More efficacious treatments have lengthened overall survival, but these treatments often result in a myriad of symptoms and financial burden that may negatively impact perceptions of cancer treatment and medication-taking behavior. Purpose: To explore cancer treatment–specific medication beliefs among women undergoing cancer treatment for MBC. Methods: A qualitative study was conducted using semi-structured interviews that were audio recorded and transcribed verbatim. A thematic analysis was conducted using ATLAS.ti 8.0 software. Inter-rater reliability was set at a threshold of 0.80. Participants were recruited from a National Cancer Institute–designated comprehensive care center. Eligibility included ≥18 years old, English speaking, confirmed MBC diagnosis, and able/willing to complete interviews via telephone or Zoom. Results: Participants (n = 16) were largely Caucasian (86.7%) and non-Hispanic (93.3%). Mean age was 55.62 years. Three major themes were revealed, with corresponding subthemes: (1) positive cancer treatment–specific medication beliefs highlighting the benefit of treatment (relief of cancer-related symptoms and medication efficacy: delayed disease progression/extended survival); (2) negative cancer treatment–specific medication beliefs that caused concern for cancer treatment (medication symptoms, side effects and drug-drug interactions, financial toxicity, lack of guarantee medication would work); and (3) dialectical cancer treatment–specific medication beliefs indicating the benefits of cancer treatment outweigh the risks. Conclusion: Overall, participants noted that the benefits of cancer treatment outweighed the risks in the context of metastatic disease. Participants understood their prognosis and that they depended on their cancer treatment for survival. Oncology providers should continue to assess and address medication beliefs over the treatment trajectory and assist MBC patients with the decisional balance between the risk and benefit of continued cancer treatment.
AB - Background/significance: Over 168,000 women are living with metastatic breast cancer (MBC) in the USA. More efficacious treatments have lengthened overall survival, but these treatments often result in a myriad of symptoms and financial burden that may negatively impact perceptions of cancer treatment and medication-taking behavior. Purpose: To explore cancer treatment–specific medication beliefs among women undergoing cancer treatment for MBC. Methods: A qualitative study was conducted using semi-structured interviews that were audio recorded and transcribed verbatim. A thematic analysis was conducted using ATLAS.ti 8.0 software. Inter-rater reliability was set at a threshold of 0.80. Participants were recruited from a National Cancer Institute–designated comprehensive care center. Eligibility included ≥18 years old, English speaking, confirmed MBC diagnosis, and able/willing to complete interviews via telephone or Zoom. Results: Participants (n = 16) were largely Caucasian (86.7%) and non-Hispanic (93.3%). Mean age was 55.62 years. Three major themes were revealed, with corresponding subthemes: (1) positive cancer treatment–specific medication beliefs highlighting the benefit of treatment (relief of cancer-related symptoms and medication efficacy: delayed disease progression/extended survival); (2) negative cancer treatment–specific medication beliefs that caused concern for cancer treatment (medication symptoms, side effects and drug-drug interactions, financial toxicity, lack of guarantee medication would work); and (3) dialectical cancer treatment–specific medication beliefs indicating the benefits of cancer treatment outweigh the risks. Conclusion: Overall, participants noted that the benefits of cancer treatment outweighed the risks in the context of metastatic disease. Participants understood their prognosis and that they depended on their cancer treatment for survival. Oncology providers should continue to assess and address medication beliefs over the treatment trajectory and assist MBC patients with the decisional balance between the risk and benefit of continued cancer treatment.
KW - Cancer treatment perceptions
KW - Medication beliefs
KW - Metastatic breast cancer
UR - http://www.scopus.com/inward/record.url?scp=85129705297&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129705297&partnerID=8YFLogxK
U2 - 10.1007/s00520-022-07101-7
DO - 10.1007/s00520-022-07101-7
M3 - Article
C2 - 35527287
AN - SCOPUS:85129705297
SN - 0941-4355
VL - 30
SP - 6807
EP - 6815
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 8
ER -